Drug Shortage Report for IMITREX

Last updated on 2023-01-12 History
Report ID 172797
Drug Identification Number 02230418
Brand name IMITREX
Common or Proper name Sumatriptan nasal spray
Company Name GLAXOSMITHKLINE INC
Market Status MARKETED
Active Ingredient(s) SUMATRIPTAN
Strength(s) 5MG
Dosage form(s) SPRAY
Route of administration NASAL NASAL
Packaging size 2s
ATC code N02CC
ATC description ANTIMIGRAINE PREPARATIONS
Reason for shortage Delay in shipping of the drug.
Anticipated start date
Actual start date 2022-10-28
Estimated end date 2023-01-13
Actual end date 2023-01-11
Shortage status Resolved
Updated date 2023-01-12
Company comments
Health Canada comments
Tier 3 Status No
Company contact information 1-800-387-7374

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v10 2023-01-12 English Compare
v9 2023-01-11 French Compare
v8 2023-01-11 English Compare
v7 2022-12-14 French Compare
v6 2022-12-14 English Compare
v5 2022-11-23 French Compare
v4 2022-11-23 English Compare
v3 2022-10-29 English Compare
v2 2022-10-28 French Compare
v1 2022-10-28 English Compare

Showing 1 to 10 of 10